Clinical Trial Update: Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension [Phase 1]

View source ↗

Summary

A Phase 1 safety trial evaluating dialysate sodium individualization in hemodialysis patients with intradialytic hypotension was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: Yale University | Conditions: Hemodialysis, Hypotension | Phase 1 | Status: TERMINATED